ES516866A0 - Un procedimiento para preparar nuevos compuestos peptidicos. - Google Patents

Un procedimiento para preparar nuevos compuestos peptidicos.

Info

Publication number
ES516866A0
ES516866A0 ES82516866A ES516866A ES516866A0 ES 516866 A0 ES516866 A0 ES 516866A0 ES 82516866 A ES82516866 A ES 82516866A ES 516866 A ES516866 A ES 516866A ES 516866 A0 ES516866 A0 ES 516866A0
Authority
ES
Spain
Prior art keywords
procedure
peptide compounds
new peptide
preparing new
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES82516866A
Other languages
English (en)
Other versions
ES8402559A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56172515A external-priority patent/JPS5872549A/ja
Priority claimed from JP57160138A external-priority patent/JPS5951249A/ja
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Publication of ES516866A0 publication Critical patent/ES516866A0/es
Publication of ES8402559A1 publication Critical patent/ES8402559A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/02Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation
    • C07C5/10Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by hydrogenation of aromatic six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/02Halogenated hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES82516866A 1981-10-28 1982-10-27 Un procedimiento para preparar nuevos compuestos peptidicos. Expired ES8402559A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56172515A JPS5872549A (ja) 1981-10-28 1981-10-28 新規ペプチド類
JP57160138A JPS5951249A (ja) 1982-09-14 1982-09-14 新規ペプチド化合物、その製法及び該化合物を含有する医薬組成物

Publications (2)

Publication Number Publication Date
ES516866A0 true ES516866A0 (es) 1984-02-01
ES8402559A1 ES8402559A1 (es) 1984-02-01

Family

ID=26486725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES82516866A Expired ES8402559A1 (es) 1981-10-28 1982-10-27 Un procedimiento para preparar nuevos compuestos peptidicos.

Country Status (11)

Country Link
US (1) US4461724A (es)
EP (1) EP0078228B1 (es)
KR (1) KR900002560B1 (es)
AU (1) AU558454B2 (es)
BR (1) BR8206268A (es)
CA (1) CA1248699A (es)
DE (1) DE3275297D1 (es)
DK (1) DK476682A (es)
ES (1) ES8402559A1 (es)
IL (1) IL67085A (es)
NZ (1) NZ202297A (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177061A (en) * 1985-02-08 1993-01-05 Procyte Corporation Method for stimulating hair growth using GHL-Cu complexes
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
ZA877535B (en) * 1986-10-09 1988-04-11 F. Hoffmann-La Roche & Co. Aktiengesellschaft Factor ix-peptides
US5145838A (en) * 1989-08-30 1992-09-08 Procyte Corporation Methods and compositions for healing ulcers
US5023237A (en) * 1989-08-30 1991-06-11 Procyte Corporation Methods and compositions for healing ulcers
US5059588A (en) * 1989-10-13 1991-10-22 Procyte Corporation, Incorporated Methods and compositions for healing bone using gly his lys: copper
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
ATE192646T1 (de) * 1992-01-21 2000-05-15 Howard Alliger Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
CA2385551A1 (en) 1999-10-01 2001-04-12 Dmi Biosciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
EP1417055A4 (en) * 2001-07-19 2007-09-26 Dmi Biosciences Inc USE OF COPPER CHELATORS TO PREVENT THE INACTIVATION OF PROTEIN C
WO2003043518A2 (en) * 2001-11-20 2003-05-30 Dmi Biosciences, Inc. Methods and products for oral care
WO2004000042A2 (en) * 2002-06-19 2003-12-31 N.V. Nutricia Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US7217794B2 (en) * 2003-04-02 2007-05-15 Daiamed, Inc. Compounds and methods for treatment of thrombosis
BRPI0410505A (pt) * 2003-05-07 2006-06-20 Dmi Biosciences Inc métodos e produtos para cuidados orais
JP2007523908A (ja) * 2004-02-17 2007-08-23 ダイナミス セラピューティクス インコーポレイテッド フルクトサミン3キナーゼ並びにコラーゲン及びエラスチンの形成
WO2005108463A2 (en) 2004-05-03 2005-11-17 Nektar Therapeutics Al, Corporation Branched polyethylen glycol derivates comprising an acetal or ketal branching point
US20110171312A1 (en) * 2008-09-19 2011-07-14 Nektar Therapeutics Modified therapeutic peptides, methods of their preparation and use
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response

Also Published As

Publication number Publication date
IL67085A (en) 1986-04-29
CA1248699A (en) 1989-01-10
KR900002560B1 (ko) 1990-04-20
DK476682A (da) 1983-04-29
NZ202297A (en) 1985-08-30
EP0078228B1 (en) 1987-01-28
BR8206268A (pt) 1983-09-20
KR840001949A (ko) 1984-06-07
US4461724A (en) 1984-07-24
DE3275297D1 (en) 1987-03-05
EP0078228A1 (en) 1983-05-04
ES8402559A1 (es) 1984-02-01
IL67085A0 (en) 1983-02-23
AU8979082A (en) 1983-05-05
AU558454B2 (en) 1987-01-29

Similar Documents

Publication Publication Date Title
ES516866A0 (es) Un procedimiento para preparar nuevos compuestos peptidicos.
ES537520A0 (es) Un procedimiento para preparar nuevos peptidos atriales.
ES514796A0 (es) Procedimiento para preparar compuestos tetrakisazoicos.
ES534203A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES513296A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES519652A0 (es) Un procedimiento para obtener s-adenosil-metionina.
AR231308A1 (es) Un procedimiento para preparar 1-be-d-ribofuranosil-1,2,4-triazolcarboxamida rivavirina
ES517459A0 (es) Un procedimiento para preparar un dentifrico estable.
ES520364A0 (es) Un procedimiento para preparar compuestos de cefem.
ES521047A0 (es) Un procedimiento para preparar compuestos de cefem.
ES510996A0 (es) "un procedimiento para preparar compuestos de cefem".
ES518758A0 (es) Un procedimiento para preparar azetidinas.
ES509787A0 (es) "un procedimiento para preparar un peptido".
ES527304A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES539083A0 (es) Un procedimiento para preparar compuestos peptidicos sustituidos
ES523277A0 (es) Un procedimiento para preparar peptidos.
ES524772A0 (es) Un procedimiento para preparar fenilanilinas-n.sustituidas.
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES520826A0 (es) Un procedimiento para obtener compuestos de ribofuranosilselenazol-4-carboxamida.
ES517646A0 (es) Procedimiento para preparar nuevos compuestos anti-helminticos.
ES552724A0 (es) Un procedimiento para preparar nuevos compuestos de 2-oxa-0 aza-pregnano.
ES508928A0 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
ES514353A0 (es) Un procedimiento para preparar compuestos derivados de aci- dos fenoxibenzoicos.
ES508294A0 (es) "un procedimiento para preparar n-arilsulfenil-n-diariloxifosfinilmetilglicinatos de alcohilo".
ES510448A0 (es) Un procedimiento para la preparacion azaespiroalcanodionas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981201